Immune Cells Comprising Truncated NKG2D Chimeric Receptors
US 12,351,617 In forceTerm ends Mar 27, 2038 · High confidence
20-year base term ends Mar 27, 2038
Mar 27, 2018
Mar 27, 2038
Jul 8, 2025
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 27, 2018, when the earliest non-provisional application in its chain was filed (this one was filed May 10, 2022) | Mar 27, 2038 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +129 days, USPTO patent term adjustment record | Aug 3, 2038 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 11,365,236) | capped to Mar 27, 2038 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Mar 27, 2038 | High confidence |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Not on this page: the patent's family, its recorded assignments and its citation count. USPTO's assignment records, linked above, list every recorded assignment.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.